Gout Flare Risk Varies By Urate-Lowering Therapy Dosing, Pro

Urate-lowering therapy and dosing regimen impact the risk of gout flares, with greater fixed dosing linked to a greater risk of flares and prophylaxis associated with reductions in flare risk.

Related Keywords

United States , America , Michael Wiese , University Of South Australia , South Australia , North America , Gout , Flare , Urate Lowering Therapy , Prophylaxis , Febuxostat , Lesinurad , Colchicine , Rilonacept ,